$SFES
SAFEGUARD SCIENTIFICS INC

2021 Q1 Form 10-Q Financial Statement

#000143774921011302 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.700M $1.800M
YoY Change -5.56% -41.94%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.700M $1.800M
YoY Change -5.56% -41.94%
Operating Profit -$2.463M -$3.532M
YoY Change -30.27% 15.54%
Interest Expense $19.40M -$2.700M
YoY Change -818.52% -110.15%
% of Operating Profit
Other Income/Expense, Net $706.0K -$3.567M
YoY Change -119.79% 89.23%
Pretax Income $17.63M -$16.01M
YoY Change -210.1% -173.9%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $17.63M -$16.01M
YoY Change -210.1% -173.9%
Net Earnings / Revenue
Basic Earnings Per Share $0.84 -$0.77
Diluted Earnings Per Share $0.84 -$0.77
COMMON SHARES
Basic Shares Outstanding 20.90M 20.69M
Diluted Shares Outstanding 20.93M 20.69M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.80M $20.90M
YoY Change 4.31% -73.13%
Cash & Equivalents $21.80M $20.93M
Short-Term Investments
Other Short-Term Assets $600.0K $600.0K
YoY Change 0.0% -84.62%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $22.36M $21.59M
YoY Change 3.57% -73.57%
LONG-TERM ASSETS
Property, Plant & Equipment $1.736M $2.026M
YoY Change -14.31% -16.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $27.81M $29.56M
YoY Change -5.91% -39.34%
Other Assets $292.0K $1.992M
YoY Change -85.34% 179.78%
Total Long-Term Assets $64.62M $70.82M
YoY Change -8.75% -20.2%
TOTAL ASSETS
Total Short-Term Assets $22.36M $21.59M
Total Long-Term Assets $64.62M $70.82M
Total Assets $86.98M $92.41M
YoY Change -5.87% -45.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.00K $141.0K
YoY Change -87.23% 28.18%
Accrued Expenses $577.0K $568.0K
YoY Change 1.58% -73.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.978M $3.185M
YoY Change 24.9% -95.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $50.00K $1.112M
YoY Change -95.5% -45.46%
Total Long-Term Liabilities $50.00K $1.112M
YoY Change -95.5% -45.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.978M $3.185M
Total Long-Term Liabilities $50.00K $1.112M
Total Liabilities $5.992M $6.600M
YoY Change -9.21% -91.91%
SHAREHOLDERS EQUITY
Retained Earnings -$719.0M -$713.2M
YoY Change 0.81% 0.53%
Common Stock $809.3M $813.0M
YoY Change -0.46% -0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost) $9.237M $13.92M
YoY Change -33.64% -8.16%
Treasury Stock Shares $630.0K $924.0K
Shareholders Equity $81.00M $85.80M
YoY Change
Total Liabilities & Shareholders Equity $86.98M $92.41M
YoY Change -5.87% -45.79%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $17.63M -$16.01M
YoY Change -210.1% -173.9%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$2.157M -$2.551M
YoY Change -15.44% -55.88%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $8.400M -$1.500M
YoY Change -660.0% -103.5%
Cash From Investing Activities $8.419M -$1.533M
YoY Change -649.18% -103.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$88.00K -$11.00K
YoY Change 700.0% -92.62%
NET CHANGE
Cash From Operating Activities -$2.157M -$2.551M
Cash From Investing Activities $8.419M -$1.533M
Cash From Financing Activities -$88.00K -$11.00K
Net Change In Cash $6.174M -$4.095M
YoY Change -250.77% -111.09%
FREE CASH FLOW
Cash From Operating Activities -$2.157M -$2.551M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20957572
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
630000
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
688000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2021Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21750000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15601000 USD
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
588000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
462000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
22363000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
16063000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1736000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1790000 USD
CY2021Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
62593000 USD
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
50398000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
292000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
784000 USD
CY2021Q1 us-gaap Assets
Assets
86984000 USD
CY2020Q4 us-gaap Assets
Assets
69035000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
18000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
56000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3045000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2677000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
577000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
410000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
338000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
327000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3978000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3470000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1964000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2053000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
637000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
5992000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
6160000 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
2157000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2157000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
807111000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
807582000 USD
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
9237000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10200000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
80992000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
62875000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86984000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69035000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2463000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3532000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-719014000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-736639000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2463000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3532000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
706000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3567000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
53000 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
105000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
19329000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9014000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17625000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16008000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
17625000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-16008000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.84
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20902000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20686000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20930000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20686000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2157000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2551000 USD
CY2021Q1 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
9419000 USD
CY2020Q1 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
708000 USD
CY2021Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
-0 USD
CY2020Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1000000 USD
CY2021Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
1000000 USD
CY2020Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
1241000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8419000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1533000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
88000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-88000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6174000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4095000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15601000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25053000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21775000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20958000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
62875000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
17625000 USD
CY2021Q1 sfe Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
370000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
122000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
80992000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
101741000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-16008000 USD
CY2020Q1 sfe Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
72000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
85808000 USD
CY2021Q1 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
0
CY2020Q1 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
0
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20930000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21800000 USD
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
27812000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
27821000 USD
CY2021Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
33101000 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
19951000 USD
CY2021Q1 us-gaap Advances To Affiliate
AdvancesToAffiliate
1680000 USD
CY2020Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
2626000 USD
CY2021Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
62593000 USD
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
50398000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20686000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
28000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20686000
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.84
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
245000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
86000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
17625000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-16008000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20902000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20686000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
CY2021Q1 us-gaap Profit Loss
ProfitLoss
17625000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-16008000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20902000
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
447000 USD
CY2021Q1 sfe Lessee Subleaseexpected Receipts Remainder Of Fiscal Year
LesseeSubleaseexpectedReceiptsRemainderOfFiscalYear
396000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
601000 USD
CY2021Q1 sfe Lessee Sublease Expected Receipts Year One
LesseeSubleaseExpectedReceiptsYearOne
540000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
607000 USD
CY2021Q1 sfe Lessee Subleaseexpected Receipts Year Two
LesseeSubleaseexpectedReceiptsYearTwo
556000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
613000 USD
CY2021Q1 sfe Lessee Subleaseexpected Receipts Year Three
LesseeSubleaseexpectedReceiptsYearThree
573000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
619000 USD
CY2021Q1 sfe Lessee Subleaseexpected Receipts Year Four
LesseeSubleaseexpectedReceiptsYearFour
590000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
207000 USD
CY2021Q1 sfe Lessee Subleaseexpected Receipts Year Five
LesseeSubleaseexpectedReceiptsYearFive
199000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2021Q1 sfe Lessee Subleaseexpected Receipts Thereafter
LesseeSubleaseexpectedReceiptsThereafter
0 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3094000 USD
CY2021Q1 sfe Lessee Sublease Expected Receipts Total
LesseeSubleaseExpectedReceiptsTotal
2854000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
792000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2302000 USD
CY2021Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
2000000.0 USD
CY2021Q1 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
600000 USD
CY2021Q1 sfe Employee And Severance Agreement Maximum Aggregate Exposure
EmployeeAndSeveranceAgreementMaximumAggregateExposure
900000 USD
CY2015Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000.0 USD

Files In Submission

Name View Source Status
0001437749-21-011302-index-headers.html Edgar Link pending
0001437749-21-011302-index.html Edgar Link pending
0001437749-21-011302.txt Edgar Link pending
0001437749-21-011302-xbrl.zip Edgar Link pending
ex_239311.htm Edgar Link pending
ex_239312.htm Edgar Link pending
ex_239313.htm Edgar Link pending
ex_239314.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sfe-20210331.xsd Edgar Link pending
sfe-20210331_cal.xml Edgar Link unprocessable
sfe-20210331_def.xml Edgar Link unprocessable
sfe-20210331_lab.xml Edgar Link unprocessable
sfe-20210331_pre.xml Edgar Link unprocessable
sfe20210405_10q.htm Edgar Link pending
sfe20210405_10q_htm.xml Edgar Link completed
Show.js Edgar Link pending